Suppr超能文献

由该基因突变导致的常染色体显性遗传II型骨硬化症:一例报告。

Autosomal dominant osteopetrosis type II resulting from a mutation in the gene: A case report.

作者信息

Song Xiu-Li, Peng Li-Yuan, Wang Dao-Wen, Wang Hong

机构信息

Genetic Diagnostic Centre, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.

Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.

出版信息

World J Clin Cases. 2022 Jul 16;10(20):6936-6943. doi: 10.12998/wjcc.v10.i20.6936.

Abstract

BACKGROUND

Osteopetrosis is a family of extremely rare diseases caused by failure of osteoclasts and impaired bone resorption. Among them, autosomal dominant osteopetrosis type II (ADO II), related to the chloride channel 7 () gene, is the most frequent form of osteopetrosis. In this study, we report a mutation of in a patient without the family history of ADO II.

CASE SUMMARY

A 5-year-old Chinese boy with ADO II was found to have a mutation in the gene [c.746C>T (p.P249L)]. Typical clinical manifestations, including thickening of the cortex of spinal bones and long bones, non-traumatic fracture of the femoral neck, and femoral head necrosis, were found in this patient. The patient is the first reported case of ADO II with the missense mutation c.746C>T (p.P249L) of the gene reported in China. We also review the available literature on ADO II-related mutations, including baseline patient clinical features, special clinical significance, and common mutations.

CONCLUSION

Our report will enrich the understanding of mutations in ADO II patients. The possibility of a mutation should be considered in individuals who have no family history of osteopetrosis.

摘要

背景

骨质石化症是一类极为罕见的疾病,由破骨细胞功能障碍和骨吸收受损引起。其中,与氯离子通道7(CLCN7)基因相关的常染色体显性II型骨质石化症(ADO II)是骨质石化症最常见的形式。在本研究中,我们报告了1例无ADO II家族史患者的CLCN7基因突变情况。

病例摘要

一名5岁患ADO II的中国男孩被发现CLCN7基因存在[c.746C>T(p.P249L)]突变。该患者具有典型的临床表现,包括脊椎骨和长骨皮质增厚、非创伤性股骨颈骨折以及股骨头坏死。该患者是中国首例报道的携带CLCN7基因错义突变c.746C>T(p.P249L)的ADO II病例。我们还回顾了关于ADO II相关CLCN7基因突变的现有文献,包括患者的基线临床特征、特殊临床意义和常见突变。

结论

我们的报告将丰富对ADO II患者基因突变的认识。对于无骨质石化症家族史的个体,应考虑CLCN7基因突变的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a77/9297392/ab167a058d3d/WJCC-10-6936-g001.jpg

相似文献

1
Autosomal dominant osteopetrosis type II resulting from a mutation in the gene: A case report.
World J Clin Cases. 2022 Jul 16;10(20):6936-6943. doi: 10.12998/wjcc.v10.i20.6936.
3
Identification of the CLCN7 gene mutations in two Chinese families with autosomal dominant osteopetrosis (type II).
J Bone Miner Metab. 2009;27(4):444-51. doi: 10.1007/s00774-009-0051-0. Epub 2009 Mar 14.
4
Genetic Analysis of in an Old Female Patient with Type II Autosomal Dominant Osteopetrosis.
Endocrinol Metab (Seoul). 2018 Sep;33(3):380-386. doi: 10.3803/EnM.2018.33.3.380.
5
Two novel mutations of CLCN7 gene in Chinese families with autosomal dominant osteopetrosis (type II).
J Bone Miner Metab. 2016 Jul;34(4):440-6. doi: 10.1007/s00774-015-0682-2. Epub 2015 Jun 9.
6
Clinical and genetic diagnosis of autosomal dominant osteopetrosis type II in a Chinese family: A case report.
World J Clin Cases. 2023 Jan 26;11(3):700-708. doi: 10.12998/wjcc.v11.i3.700.
7
Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation.
J Clin Endocrinol Metab. 2007 Mar;92(3):771-8. doi: 10.1210/jc.2006-1986. Epub 2006 Dec 12.
9
Autosomal Dominant Osteopetrosis (ADO) Caused by a Missense Variant in the TCIRG1 Gene.
J Clin Endocrinol Metab. 2024 Jun 17;109(7):1726-1732. doi: 10.1210/clinem/dgae040.
10
Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis.
J Bone Miner Res. 2003 Oct;18(10):1740-7. doi: 10.1359/jbmr.2003.18.10.1740.

引用本文的文献

本文引用的文献

1
A Novel Variant in Regulates the Coupling of Angiogenesis and Osteogenesis.
Front Cell Dev Biol. 2020 Nov 16;8:599826. doi: 10.3389/fcell.2020.599826. eCollection 2020.
2
Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification.
Am J Hum Genet. 2019 Jun 6;104(6):1127-1138. doi: 10.1016/j.ajhg.2019.04.008. Epub 2019 May 30.
3
Novel CLCN7 mutations cause autosomal dominant osteopetrosis type II and intermediate autosomal recessive osteopetrosis.
Mol Med Rep. 2019 Jun;19(6):5030-5038. doi: 10.3892/mmr.2019.10123. Epub 2019 Apr 3.
4
A Case of Autosomal Dominant Osteopetrosis Type 2 with a Gene Mutation.
J Clin Res Pediatr Endocrinol. 2019 Nov 22;11(4):439-443. doi: 10.4274/jcrpe.galenos.2019.2018.0229. Epub 2019 Feb 14.
5
Genetic Analysis of in an Old Female Patient with Type II Autosomal Dominant Osteopetrosis.
Endocrinol Metab (Seoul). 2018 Sep;33(3):380-386. doi: 10.3803/EnM.2018.33.3.380.
6
Genetic Testing in Clinical Settings.
Am J Kidney Dis. 2018 Oct;72(4):569-581. doi: 10.1053/j.ajkd.2018.02.351. Epub 2018 Apr 11.
8
Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group.
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3111-3123. doi: 10.1210/jc.2017-01127.
10
Autosomal dominant osteopetrosis associated with renal tubular acidosis is due to a CLCN7 mutation.
Am J Med Genet A. 2016 Nov;170(11):2988-2992. doi: 10.1002/ajmg.a.37755. Epub 2016 Aug 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验